For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Inhaled nitric oxide therapy is successful in treating ARDS, PPH, and PPHN because it reduces pulmonary artery pressure and vasodilates the blood vessels in the ventilated regions of the lung
Scope of the Report:
Durability and lightweight are the meritorious features that increase the demand for portable nitric oxide therapy systems. Relatively low cost, versatility and easy fabrication of the auxiliary holding devices with the main ventilation unit makes fixed nitric oxide therapy systems a lucrative option in the ambulatory care and hospitals.
Hospitals and clinics widely utilize the nitric oxide inhalation therapy in the neonate and intensive care unit to address ailments related to pulmonary disorders and increasing demand for pediatric cardiopulmonary bypass surgery procedures for treating cardiopulmonary ailments. Homecare settings finds huge application of nitric oxide therapy systems for the rehabilitation of geriatric patients suffering with acute respiratory distress syndrome.
North America is the market leader in nitric oxide therapy systems due to the rising prevalence of acute respiratory distress syndrome in the adult population and the presence of key players actively engaged in the manufacturing of nitric oxide therapy systems. Asia Pacific will dominate the market in the near future on account of the rising prevalence of neonate pulmonary hypertension. Competitive market formed due to the emergence of local providers of nitric oxide therapy systems contribute to the growth of Asia Pacific market.
The worldwide market for Nitric Oxide Therapy System is expected to grow at a CAGR of roughly 5.3% over the next five years, will reach 34 million US$ in 2024, from 25 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nitric Oxide Therapy System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Bellerophon Therapeutics
- BOC Healthcare
- Dan Hammer Health LTD
- EKU Elektronik GmbH
- GeNO LLC
- International Biomedical
- SLE
- Mallinckrodt Pharmaceuticals
- Praxair, Inc.
- Vapotherm
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Protable System
- Fixed System
Market Segment by Applications, can be divided into
- Hospitals
- Homecare Settings
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nitric Oxide Therapy System product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nitric Oxide Therapy System, with price, sales, revenue and global market share of Nitric Oxide Therapy System in 2017 and 2018.
Chapter 3, the Nitric Oxide Therapy System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nitric Oxide Therapy System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nitric Oxide Therapy System market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nitric Oxide Therapy System sales channel, distributors, customers, research findings and conclusion, appendix and data source.